HISTOPLASMA CAPSULATUM - ANVISA Registration 81504790103
Access comprehensive regulatory information for HISTOPLASMA CAPSULATUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81504790103 and manufactured by IMMY INC. The registration is held by PASSROD IMPORTAÇÃO E EXPORTAÇÃO DE PRODUTOS PARA SAÚDE LTDA - ME with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 2 companies making the same product including DIASORIN MOLECULAR LLC, MIRAVISTA DIAGNOSTICS, LLC, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
81504790103
25351625780201964
26185222000110
Company Information
Dates and Status
Jan 27, 2020
VIGENTE
09/18/2025 19:00:01
HISTOPLASMA CAPSULATUM
Família de teste de LFA de antígeno urinário para histoplasma
MIRAVISTA DIAGNOSTICS, LLC
82142390001
Nov 18, 2021
HISTOPLASMA CAPSULATUM
Histoplasma DxSelect™
DIASORIN MOLECULAR LLC
10259610132
Jan 30, 2012

